Abstract
The objective of the study was to compare the therapeutic outcomes between the ultrasonography-guided (USG) and the fluoroscopy-guided (FG) mini-percutaneous nephrolithotomy (MPCNL) for the treatment of large or complex upper urinary tract stones (S.T.O.N.E. scores 5–11) in patients with autosomal dominant polycystic kidney disease (ADPKD). 45 ADPKD patients who were suffering from large or complex upper urinary tract stones (S.T.O.N.E. scores 5–11, mean score 7.6) in 45 renal units were accrued into this retrospective study. They were treated by either USG (20 patients) or FG (25 patients) MPCNL in our center. The treatment results as well as the complications according to the modified Clavien system were assessed and compared. The FG MPCNL group had a higher success rate in accessing the targeted calyces than the USG MPCNL group (96 vs. 70 %, p = 0.048). There was no significant difference observed between the two groups with respect to the operative time, the mean hemoglobin drop, and the stone free rate. The overall operative complications and the perioperative blood transfusion rates were significantly higher in the USG than the FG MPCNL groups, 71.4 vs. 29.2 %, p = 0.011, and 35.7 vs. 4.2 %, p = 0.018, respectively. There was no significant difference between these two groups in terms of major complications (Clavien score 3a–4a) (p = 0.542). In our center, the FG MPCNL was a superior modality to the USG MPCNL in the treatment of large or complex kidney stones in the ADPKD patients. It resulted in higher successful calyceal punctures and less operative complications.
Similar content being viewed by others
References
Nishiura JL, Neves RF, Eloi SR, Cintra SM, Ajzen SA, Heilberg IP (2009) Evaluation of nephrolithiasis in autosomal dominant polycystic kidney disease patients. Clin J Am Soc Nephrol 4(4):838–844
Torres VE, Wilson DM, Hattery RR, Segura JW (1993) Renal stone disease in autosomal dominant polycystic kidney disease. Am J Kidney Dis 22(4):513–519
Umbreit EC, Childs MA, Patterson DE, Torres VE, LeRoy AJ, Gettman MT (2010) Percutaneous nephrolithotomy for large or multiple upper tract calculi and autosomal dominant polycystic kidney disease. J Urol 183(1):183–187
Ellison DH, Ingelfinger JR (2014) A quest-halting the progression of autosomal dominant polycystic kidney disease. N Engl J Med 371(24):2329–2331
Grantham JJ (2008) Clinical practice. Autosomal dominant polycystic kidney disease. N Engl J Med 359(14):1477–1485
Ng CS, Yost A, Streem SB (2000) Nephrolithiasis associated with autosomal dominant polycystic kidney disease: contemporary urological management. J Urol 163(3):726–729
Lei M, Zhu W, Wan SP, Liu Y, Zeng G, Yuan J (2014) Safety and efficacy of minimally invasive percutaneous nephrolithotomy in patients with autosomal dominant polycystic kidney disease. J Endourol 28(1):17–22
Zhang J, Zhang J, Xing N (2014) Polycystic kidney disease with renal calculi treated by percutaneous nephrolithotomy: a report of 11 cases. Urol Int 92(4):427–432
Jackman SV, Docimo SG, Cadeddu JA, Bishoff JT, Kavoussi LR, Jarrett TW (1998) The “mini-perc” technique: a less invasive alternative to percutaneous nephrolithotomy. World J Urol 16(6):371–374
Abdelhafez MF, Bedke J, Amend B, ElGanainy E, Aboulella H, Elakkad M, Nagele U, Stenzl A, Schilling D (2012) Minimally invasive percutaneous nephrolitholapaxy (PCNL) as an effective and safe procedure for large renal stones. BJU Int 110(11 Pt C):E1022–E1026
Zeng G, Zhao Z, Wan S, Mai Z, Wu W, Zhong W, Yuan J (2013) Minimally invasive percutaneous nephrolithotomy for simple and complex renal caliceal stones: a comparative analysis of more than 10,000 cases. J Endourol 27(10):1203–1208
Ravine D, Gibson RN, Walker RG, Sheffield LJ, Kincaid-Smith P, Danks DM (1994) Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1. Lancet 343(8901):824–827
Okhunov Z, Friedlander JI, George AK, Duty BD, Moreira DM, Srinivasan AK, Hillelsohn J, Smith AD, Okeke Z (2013) S.T.O.N.E. nephrolithometry: novel surgical classification system for kidney calculi. Urology 81(6):1154–1160
Zeng G, Zhao Z, Zhong W, Wu K, Chen W, Wu W, Xiao C, Liu Y (2013) Evaluation of a novel fascial dilator modified with scale marker in percutaneous nephrolithotomy for reducing the X-ray exposure: a randomized clinical study. J Endourol 27(11):1335–1340
Türk C, Knoll T, Petrik A, Sarica K, Skolarikos A, Straub M, Seitz C (2015) Guidelines on urolithiasis, uroweb. http://uroweb.org/wp-content/uploads/EAU-Guidelines-Urolithiasis-2015-v2.pdf
Singh V, Sinha RJ, Gupta DK (2013) Percutaneous nephrolithotomy in autosomal dominant polycystic kidney disease: is it different from percutaneous nephrolithotomy in normal kidney? Curr Urol 7(1):7–13
Al-Kandari AM, Shoma AM, Eraky I, El-Kenawy MR, Al-Eezi H, El-Kappany HA (2009) Percutaneous nephrolithotomy for management of upper urinary tract calculi in patients with autosomal dominant polycystic kidney disease. Urology 74(2):273–277
Kamphuis GM, Baard J, Westendarp M, de la Rosette JJ (2015) Lessons learned from the CROES percutaneous nephrolithotomy global study. World J Urol 33(2):223–233
Srivastava A, Bansal R, Srivastava A, Chaturvedi S, Ranjan P, Ansari MS, Yadav A, Kapoor R (2012) Percutaneous nephrolithotomy in polycystic kidney disease: is it safe and effective? Int Urol Nephrol 44(3):725–730
Mufti UB, Nalagatla SK (2010) Nephrolithiasis in autosomal dominant polycystic kidney disease. J Endourol 24(10):1557–1561
Chen H, Qi L, Zu X, Liu L, Cao Z, Zeng F, Niu J, Cui Y, Wang L (2014) Percutaneous intrarenal cyst marsupialization and simultaneous nephrolithotomy in selected patients: killing two birds with one stone? Urology 84(6):1267–1271
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflicts of interest.
Ethical approval
For this type of study, formal consent is not required.
Rights and permissions
About this article
Cite this article
Sun, H., Zhang, Z., Huang, G. et al. Fluoroscopy versus ultrasonography guided mini-percutaneous nephrolithotomy in patients with autosomal dominant polycystic kidney disease. Urolithiasis 45, 297–303 (2017). https://doi.org/10.1007/s00240-016-0901-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00240-016-0901-x